[Multiple sclerosis. What about treatment with monoclonal antibodies?]

Rev Prat. 2010 Mar 20;60(3):304-6.
[Article in French]
No abstract available

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm / therapeutic use
  • Daclizumab
  • Humans
  • Immunoglobulin G / therapeutic use
  • Immunologic Factors / therapeutic use
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm
  • Immunoglobulin G
  • Immunologic Factors
  • Natalizumab
  • Alemtuzumab
  • Rituximab
  • Daclizumab